WallStreetZenWallStreetZen

NASDAQ: AMPH
Amphastar Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AMPH

Based on 5 analysts offering 12 month price targets for Amphastar Pharmaceuticals Inc

Min Forecast
$25.00+3.18%
Avg Forecast
$31.60+30.42%
Max Forecast
$36.00+48.58%

Should I buy or sell AMPH stock?

Based on 5 analysts offering ratings for Amphastar Pharmaceuticals Inc.

Buy
Strong Buy
1 analysts 20%
Buy
1 analysts 20%
Hold
3 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although AMPH's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates AMPH as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their AMPH stock forecasts and price targets.

AMPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-22
lockedlocked$00.00+00.00%2025-08-26
lockedlocked$00.00+00.00%2025-08-08
lockedlocked$00.00+00.00%2025-05-12
lockedlocked$00.00+00.00%2025-05-08

1 of 1

Forecast return on equity

Is AMPH forecast to generate an efficient return?

Company
24.26%
Industry
300.73%
Market
230.21%
AMPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMPH forecast to generate an efficient return on assets?

Company
11.21%
Industry
164.57%
AMPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMPH earnings per share forecast

What is AMPH's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$3.40+16.43%
Avg 2 year Forecast
$3.72+27.55%
Avg 3 year Forecast
$3.98+36.23%
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AMPH revenue forecast

What is AMPH's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$737.4M+0.92%
Avg 2 year Forecast
$778.9M+6.6%
Avg 3 year Forecast
$803.1M+9.91%
AMPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMPH earnings growth forecast

How is AMPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
10.98%
Industry
369.93%
Market
43.04%
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AMPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AMPH revenue growth forecast

How is AMPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
3.34%
Industry
130.59%
Market
26.12%
AMPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMPH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
AMPH$25.31$31.60+24.85%Buy
EVO$3.35N/AN/A
COLL$35.85$42.33+18.08%Buy
DVAX$10.30$32.00+210.68%Buy
HROW$35.42$68.50+93.39%Strong Buy
View Top Pharmaceutical Stocks

Amphastar Pharmaceuticals Stock Forecast FAQ

Is Amphastar Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: AMPH) stock is to Buy AMPH stock.

Out of 5 analysts, 1 (20%) are recommending AMPH as a Strong Buy, 1 (20%) are recommending AMPH as a Buy, 3 (60%) are recommending AMPH as a Hold, 0 (0%) are recommending AMPH as a Sell, and 0 (0%) are recommending AMPH as a Strong Sell.

If you're new to stock investing, here's how to buy Amphastar Pharmaceuticals stock.

What is AMPH's earnings growth forecast for 2025-2027?

(NASDAQ: AMPH) Amphastar Pharmaceuticals's forecast annual earnings growth rate of 10.98% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 366.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.21%.

Amphastar Pharmaceuticals's earnings in 2025 is $141,627,000.On average, 8 Wall Street analysts forecast AMPH's earnings for 2025 to be $160,268,175, with the lowest AMPH earnings forecast at $145,056,392, and the highest AMPH earnings forecast at $173,731,098. On average, 8 Wall Street analysts forecast AMPH's earnings for 2026 to be $175,564,808, with the lowest AMPH earnings forecast at $151,985,838, and the highest AMPH earnings forecast at $215,307,771.

In 2027, AMPH is forecast to generate $187,519,280 in earnings, with the lowest earnings forecast at $161,225,099 and the highest earnings forecast at $224,217,058.

What is AMPH's revenue growth forecast for 2025-2027?

(NASDAQ: AMPH) Amphastar Pharmaceuticals's forecast annual revenue growth rate of 3.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 129.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.15%.

Amphastar Pharmaceuticals's revenue in 2025 is $730,659,000.On average, 8 Wall Street analysts forecast AMPH's revenue for 2025 to be $34,759,889,888, with the lowest AMPH revenue forecast at $32,799,375,343, and the highest AMPH revenue forecast at $36,557,774,590. On average, 8 Wall Street analysts forecast AMPH's revenue for 2026 to be $36,717,104,697, with the lowest AMPH revenue forecast at $34,000,479,229, and the highest AMPH revenue forecast at $40,859,216,096.

In 2027, AMPH is forecast to generate $37,856,927,773 in revenue, with the lowest revenue forecast at $33,630,908,802 and the highest revenue forecast at $42,170,625,441.

What is AMPH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AMPH) forecast ROA is 11.21%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 163%.

What is AMPH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year AMPH price target, the average AMPH price target is $31.60, with the highest AMPH stock price forecast at $36.00 and the lowest AMPH stock price forecast at $25.00.

On average, Wall Street analysts predict that Amphastar Pharmaceuticals's share price could reach $31.60 by Oct 22, 2026. The average Amphastar Pharmaceuticals stock price prediction forecasts a potential upside of 24.85% from the current AMPH share price of $25.31.

What is AMPH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AMPH) Amphastar Pharmaceuticals's current Earnings Per Share (EPS) is $2.92. On average, analysts forecast that AMPH's EPS will be $3.40 for 2025, with the lowest EPS forecast at $3.08, and the highest EPS forecast at $3.69. On average, analysts forecast that AMPH's EPS will be $3.72 for 2026, with the lowest EPS forecast at $3.22, and the highest EPS forecast at $4.57. In 2027, AMPH's EPS is forecast to hit $3.98 (min: $3.42, max: $4.76).

What is AMPH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AMPH) forecast ROE is 24.26%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.